Combination therapy with biologic agents in rheumatoid arthritis: perils and promise
- PMID: 9751086
- DOI: 10.1002/1529-0131(199809)41:9<1548::AID-ART4>3.0.CO;2-I
Combination therapy with biologic agents in rheumatoid arthritis: perils and promise
Comment on
-
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.Arthritis Rheum. 1998 Sep;41(9):1552-63. doi: 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W. Arthritis Rheum. 1998. PMID: 9751087 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical